Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

No phase data

Trial Status

Recruiting1
Other2

Role Distribution

Other Roles3

Activity Timeline

Clinical Trials (3)

NCT06061276Not ApplicableUnknown
bTAE-HAIC Combined With System Therapy for Intermediate-advanced Huge HCC
CamrelizumabHepatocellular CarcinomaImmunotherapy+2 more
StudydirectorStart date: 2024-05-20
NCT06070636Not ApplicableUnknown
bTAE-HAIC Combined With Lenvatinib and Sintilimab for Infiltrative Hepatocellular Carcinoma
Hepatocellular CarcinomaImmunotherapyLenvatinib+2 more
StudydirectorStart date: 2024-05-20
NCT06265350Not ApplicableRecruiting
Cryoablation Combined With Cardonilizumab and Bevacizumab in Hepatocellular Carcinoma With Pulmonary Metastases
BevacizumabCadonilimabCryoablation+3 more
StudydirectorStart date: 2024-02-02

Research Network

Collaboration Network

4 collaborators·3 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Jinhua Huang, MD

Sun Yat-sen University

Similar
1 trials

Shared therapeutic areas:

BevacizumabCadonilimabCryosurgery+3 more

Worked with same sponsors:

Sun Yat-sen University
Collaborated on 1 trial
Similarity Score64%

Jinhua Huang, Professor

Sun Yat-sen University

Similar
1 trials

Shared therapeutic areas:

Carcinoma, HepatocellularImmunotherapyLenvatinib+2 more

Worked with same sponsors:

Sun Yat-sen University
Collaborated on 1 trial
Similarity Score54%

Jinhua Huang, Profession

Sun Yat-sen University

Similar
1 trials

Shared therapeutic areas:

CamrelizumabCarcinoma, HepatocellularImmunotherapy+2 more

Worked with same sponsors:

Sun Yat-sen University
Collaborated on 1 trial
Similarity Score54%

Jeong Min Lee, MD

Seoul National University Hospital

Related
34 trials

Shared therapeutic areas:

Carcinoma, HepatocellularLiver Diseases
Similarity Score5%

Lei Li, M.D.

Peking Union Medical College Hospital

Related
46 trials

Shared therapeutic areas:

ImmunotherapyBevacizumab
Similarity Score5%

Xiaolong Qi, MD

LanZhou University

Related
8 trials

Shared therapeutic areas:

Liver Diseases
Similarity Score3%

Ming Shi, MD

Sun Yat-sen University

Related
11 trials

Shared therapeutic areas:

Carcinoma, Hepatocellular

Worked with same sponsors:

Sun Yat-sen University
Similarity Score3%

Averell Sherker, MD

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Related
11 trials

Shared therapeutic areas:

Liver Diseases
Similarity Score3%

Brennan Spiegel, MD, MSHS

Cedars-Sinai Medical Center

Related
10 trials

Shared therapeutic areas:

Liver Cancer Stage IV
Similarity Score3%

Wenhong Zhang, MD

Huashan Hospital

Related
4 trials

Shared therapeutic areas:

Liver Diseases
Similarity Score3%

Publications (0)

No publications found for this investigator.

Clinical Trials (3)

Showing 3 of 3 trials

NCT06061276Not ApplicableStudyDirector

bTAE-HAIC Combined With System Therapy for Intermediate-advanced Huge HCC

CamrelizumabHepatocellular CarcinomaImmunotherapy+2 more
Unknown
NCT06070636Not ApplicableStudyDirector

bTAE-HAIC Combined With Lenvatinib and Sintilimab for Infiltrative Hepatocellular Carcinoma

Hepatocellular CarcinomaImmunotherapyLenvatinib+2 more
Unknown
NCT06265350Not ApplicableStudyDirector

Cryoablation Combined With Cardonilizumab and Bevacizumab in Hepatocellular Carcinoma With Pulmonary Metastases

BevacizumabCadonilimabCryoablation+3 more
Recruiting

All 3 trials loaded